Pacific Oaks Medical Group & Subsidiary - Medicare Primary Care in Beverly Hills, CA

Pacific Oaks Medical Group & Subsidiary is a medicare enrolled primary clinic (General Practice) in Beverly Hills, California. The current practice location for Pacific Oaks Medical Group & Subsidiary is 150 N Robertson Blvd, Suite 300, Beverly Hills, California. For appointments, you can reach them via phone at (310) 652-2562. The mailing address for Pacific Oaks Medical Group & Subsidiary is 150 N Robertson Blvd Ste 300, Beverly Hills, California and phone number is (310) 652-2562.

Pacific Oaks Medical Group & Subsidiary is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1225127566. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (310) 652-2562.

Contact Information

Pacific Oaks Medical Group & Subsidiary
150 N Robertson Blvd
Suite 300
Beverly Hills
CA 90211-2142
(310) 652-2562
(310) 967-3698

Primary Care Clinic Profile

Full NamePacific Oaks Medical Group & Subsidiary
SpecialityGeneral Practice
Location150 N Robertson Blvd, Beverly Hills, California
Authorized Official Name and PositionAnthony J Scarsella (AUTHORIZED OFFICIAL)
Authorized Official Contact3106522562
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Pacific Oaks Medical Group & Subsidiary
150 N Robertson Blvd Ste 300
Beverly Hills
CA 90211-2145

Ph: (310) 652-2562
Pacific Oaks Medical Group & Subsidiary
150 N Robertson Blvd
Suite 300
Beverly Hills
CA 90211-2142

Ph: (310) 652-2562

NPI Details:

NPI Number1225127566
Provider Enumeration Date10/12/2006
Last Update Date07/08/2019

Medicare PECOS Information:

Medicare PECOS PAC ID1951337468
Medicare Enrollment IDO20050714001063

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Pacific Oaks Medical Group & Subsidiary such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225127566NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208D00000XGeneral Practice (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Pacific Oaks Medical Group & Subsidiary acts as a billing entity for following providers:
Provider NameSteven J Waltrip
Provider TypePractitioner - Orthopedic Surgery
Provider IdentifiersNPI Number: 1467423046
PECOS PAC ID: 8123919404
Enrollment ID: I20040324000868

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameJohn Kowalczyk
Provider TypePractitioner - Urology
Provider IdentifiersNPI Number: 1548254089
PECOS PAC ID: 0042273989
Enrollment ID: I20041110001255

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameRamprasad C Dandillaya
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316900236
PECOS PAC ID: 2062425556
Enrollment ID: I20060731000253

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameDouglas David Davies
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1326073222
PECOS PAC ID: 4688841380
Enrollment ID: I20120314000801

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameBryan Gaudio
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1679865885
PECOS PAC ID: 6204154701
Enrollment ID: I20150414000000

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameDavid Razmik Alajajian
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1215354337
PECOS PAC ID: 4183997646
Enrollment ID: I20170905001062

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameJack Richard O'brien
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1851749766
PECOS PAC ID: 2466788385
Enrollment ID: I20190730001529

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameDeacon E Farrell
Provider TypePractitioner - Pain Management
Provider IdentifiersNPI Number: 1467837377
PECOS PAC ID: 3870921653
Enrollment ID: I20201228000800

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameMarcus Tellez
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1144753773
PECOS PAC ID: 0941574438
Enrollment ID: I20210113000503

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

Provider NameDavid Lester Boyd
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1114657160
PECOS PAC ID: 3173991627
Enrollment ID: I20221115001449

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more Medical News

› Verified 2 days ago

News Archive

Expansion of Australia's bowel cancer screening program could save 30 lives each week

New research has revealed that as many as 5 million Australians are missing out on bowel cancer screening tests that could save their lives and according to new data on bowel cancer screening released last week there is an urgent for all Australians over 50 to be screened.

Researchers find way to make pediatric brain cancers respond better to therapies

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Intelligent Hospital Association recognizes Ochsner with Best Comprehensive Integration award

The Intelligent Hospital Association today announced that Ochsner Health System was awarded the Best Comprehensive Integration for 2014. The award is given to a hospital or health system that effectively and seamlessly integrates technologies to provide a comprehensive solution in a health care facility.

Read more News

› Verified 2 days ago


General Practice in Beverly Hills, CA

Treatmedngo
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8950 W Olympic Blvd Ste 103&104, Beverly Hills, CA 90211
Phone: 310-274-8080    
Refael Medical, Inc.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 8200 Wilshire Blvd, Beverly Hills, CA 90211
Phone: 310-879-7167    Fax: 310-933-5688
Michael D. Borookhim, M.d., Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 9301 Wilshire Blvd, Suite 602, Beverly Hills, CA 90210
Phone: 310-288-0881    
Ultrasound Specialists Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 9001 Wilshire Blvd, Suite 106, Beverly Hills, CA 90211
Phone: 310-273-8885    
Kaiser Permanente
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 204 S Arnaz Dr Apt 3, Beverly Hills, CA 90211
Phone: 213-215-5142    
Nancy P. Rahnama, M.d., A.p.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 421 N Rodeo Dr, Penthouse Number 1, Beverly Hills, CA 90210
Phone: 310-299-7373    Fax: 310-432-6647
Laurence Seigler, M.d. Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 435 N Bedford Dr, Suite 308, Beverly Hills, CA 90210
Phone: 310-274-6158    Fax: 310-274-5709

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.